Cargando…
Kinetics and performance of the Abbott architect SARS-CoV-2 IgG antibody assay
Autores principales: | Hamilton, Fergus, Muir, Peter, Attwood, Marie, Vipond, Alan Noela Barry, Hopes, Richard, Moran, Ed, Maskell, Nick, Warwick, Deborah, Albur, Mahableshwar, Turner, Jonathan, MacGowan, Alasdair, Arnold, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd on behalf of The British Infection Association.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391977/ https://www.ncbi.nlm.nih.gov/pubmed/32739487 http://dx.doi.org/10.1016/j.jinf.2020.07.031 |
Ejemplares similares
-
Early warning score: a dynamic marker of severity and prognosis in patients with Gram-negative bacteraemia and sepsis
por: Albur, Mahableshwar, et al.
Publicado: (2016) -
A comparative evaluation between the Abbott Panbio™ COVID-19 IgG/IgM rapid test device and Abbott Architect™ SARS CoV-2 IgG assay
por: Batra, Rahul, et al.
Publicado: (2020) -
Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect
por: Maine, Gabriel N., et al.
Publicado: (2020) -
Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho
por: Bryan, Andrew, et al.
Publicado: (2020) -
Longitudinal evaluation of the Abbott ARCHITECT SARS-CoV-2 IgM and IgG assays in a pediatric population
por: Interiano, Cristina, et al.
Publicado: (2021)